ACTIVE

MBM PHARMA

Financial year 2025 · closed on 31/12/2025
Net result
354,9 k €
+27.9% YoY
Gross margin
1 M €
+12.6% YoY
Equity
221,8 k €
-10.9% YoY
Workforce
9,7 ETP
-2.0% YoY

What does MBM PHARMA do?

MBM PHARMA is a Private company with limited liability incorporated in 1994. Its main activity is: Accounting, bookkeeping and auditing activities; tax consultancy. Its registered office is in Auderghem. It employs on average 9,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0454.016.517
Incorporation
13/12/1994
Legal form
Private company with limited liability
Registered office
Avenue Tedesco 7
1160 Auderghem · BruxellesSee on map
Contributed capital
90 950,89 €
Latest accounts
31/12/2025
Average workforce
9,7 ETP
Joint committees (2)
  • 218
  • 336
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 20 financial years

20252024202320222021202020192018201720162015201420132012201120102009200820072006
Income statement
Gross margin1 M €900,3 k €992 k €975,6 k €852 k €677,7 k €802,6 k €854,7 k €806,8 k €733,4 k €706,5 k €664,8 k €987,2 k €791,3 k €672,5 k €662,3 k €682,9 k €594,9 k €619,8 k €449,3 k €
EBITDA433,7 k €343,7 k €398,8 k €351 k €317,1 k €221,6 k €358,8 k €439,3 k €345,7 k €344,5 k €330,4 k €293,3 k €569 k €444 k €398,6 k €437,8 k €472,5 k €353,4 k €379 k €255,5 k €
Operating result433,7 k €343,7 k €386,3 k €330,6 k €296,7 k €201,2 k €341,2 k €335,4 k €237,1 k €227,8 k €210,7 k €164,9 k €440,3 k €323,5 k €289,9 k €326,6 k €360,3 k €251,3 k €234,9 k €190,5 k €
Net result354,9 k €277,5 k €317,3 k €264,5 k €234 k €143,9 k €249,8 k €245 k €154,8 k €144 k €124 k €85,2 k €261,3 k €181,6 k €156,5 k €179,7 k €189,8 k €113 k €127,6 k €109 k €
Balance sheet
Equity221,8 k €249 k €267,5 k €294,2 k €159,3 k €147,3 k €103,4 k €49,6 k €676,6 k €557,8 k €437,8 k €581,7 k €496,6 k €235,2 k €178,7 k €139,8 k €80,2 k €40,4 k €37,3 k €69,7 k €
Total assets872,2 k €779,6 k €835,5 k €643,7 k €640 k €440,2 k €446,4 k €1,3 M €1,3 M €1,2 M €1,4 M €1,5 M €1,5 M €1,3 M €1,4 M €1,4 M €1,5 M €1,5 M €1,4 M €1,1 M €
Cash318,3 k €614,1 k €421,7 k €359,8 k €395 k €270,7 k €272,7 k €446,5 k €300,5 k €351,3 k €396,7 k €322,7 k €178,7 k €251 k €267,1 k €170,1 k €182,5 k €200,4 k €99,6 k €20,4 k €
Debts650,4 k €530,7 k €568 k €349,5 k €480,7 k €292,9 k €343 k €1,3 M €576 k €663,5 k €998,2 k €869,7 k €1 M €1,1 M €1,2 M €1,3 M €1,4 M €1,4 M €1,4 M €1 M €
Other
Workforce9,7 ETP9,9 ETP11,4 ETP12,1 ETP11,8 ETP10,9 ETP10,0 ETP10,1 ETP10,1 ETP9,6 ETP8,8 ETP9,1 ETP9,4 ETP8,8 ETP6,8 ETP6,2 ETP6,4 ETP6,8 ETP6,9 ETP5,6 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 7 ended

Active mandates

VV FINANCE

Director · since 13 mars 2024 · 0787.866.563

Represented by Jean-Philippe WYDOCK

Active
MBM Groupe

Director · since 06 décembre 2013 · 0542.637.202

Represented by CHRISTOPHE DEREUME

Active
THIERRY GRAULICH

Director · since 11 mars 2000

Active

Ended mandates

MBM Groupe

Manager · since 06 décembre 2013 · 0542.637.202

Represented by CHRISTOPHE DEREUME

Ended
MBM Groupe

Manager · since 06 décembre 2013 · 0542.637.202

Represented by CHRISTOPHE DEREUME

Ended
MBM PHARMA

Manager · since 06 décembre 2013 · 0454.016.517

Represented by CHRISTOPHE DEREUME

Ended
THIERRY GRAULICH

Manager · since 11 mars 2000

Ended
At this address

Other companies at this address

CompanyCBE no.
1000.774.239
0507.845.775
0810.711.053
0818.511.833
AMAND & COActive
0463.663.958
BECOVAActive
0450.518.280
0476.515.567
BV GROUPActive
0447.041.821
0666.768.496
0668.445.311
HAZARD AVOCATActive
0778.460.929
IMMO TEDESCOActive
1024.305.647
0725.840.805
0476.943.159
LAWSJEActive
0782.626.880
0828.928.247
0866.661.940
MBM CogevalActive
0876.743.408
MBM GroupeActive
0542.637.202
MBM MedicalActive
0824.534.642
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date26/06/202601/07/202521/06/202429/06/202318/03/202202/07/2021
General meeting05/06/202606/06/202507/06/202402/06/202318/02/202204/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

20 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202505/06/202626/06/2026FrenchPDF
Abridged model31/12/202406/06/202501/07/2025FrenchPDF
Abridged model31/12/202307/06/202421/06/2024FrenchPDF
Abridged model31/12/202202/06/202329/06/2023FrenchPDF
Abridged model31/12/202118/02/202218/03/2022FrenchPDF
Abridged model31/12/202004/06/202102/07/2021FrenchPDF
Abridged model31/12/201905/06/202009/07/2020FrenchPDF
Abridged model31/12/201807/06/201921/06/2019FrenchPDF
Abridged model31/12/201701/06/201821/08/2018FrenchPDF
Abridged model31/12/201602/06/201723/06/2017FrenchPDF
Abridged model31/12/201503/06/201627/06/2016FrenchPDF
Abridged model31/12/201405/06/201510/08/2015FrenchPDF
Abridged model31/12/201306/06/201410/07/2014FrenchPDF
Abridged model31/12/201207/06/201312/06/2013FrenchPDF
Abridged model31/12/201101/06/201225/06/2012FrenchPDF
Abridged model31/12/201003/06/201109/09/2011FrenchPDF
Abridged model31/12/200904/06/201025/06/2010FrenchPDF
Abridged model31/12/200805/06/200904/09/2009FrenchPDF
Abridged model31/12/200706/06/200807/08/2008FrenchPDF
Abridged model31/12/200601/06/200711/06/2007FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 7 ended

Active mandates

VV FINANCE

Director · since 13 mars 2024 · 0787.866.563

Represented by Jean-Philippe WYDOCK

Active
MBM Groupe

Director · since 06 décembre 2013 · 0542.637.202

Represented by CHRISTOPHE DEREUME

Active
THIERRY GRAULICH

Director · since 11 mars 2000

Active

Ended mandates

MBM Groupe

Manager · since 06 décembre 2013 · 0542.637.202

Represented by CHRISTOPHE DEREUME

Ended
MBM Groupe

Manager · since 06 décembre 2013 · 0542.637.202

Represented by CHRISTOPHE DEREUME

Ended
MBM PHARMA

Manager · since 06 décembre 2013 · 0454.016.517

Represented by CHRISTOPHE DEREUME

Ended
THIERRY GRAULICH

Manager · since 11 mars 2000

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Registered office13/03/2026
    SIEGE SOCIAL
    PDF
  • Mandates04/11/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Restructuring20/04/2022
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Restructuring23/02/2022
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
    PDF
  • Mandates24/12/2019
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/04/2014
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates31/12/2013
    DENOMINATION
    PDF
  • Mandates27/07/2005
    SIEGE SOCIAL - OBJET - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - CAPITAL, ACTIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025354,9 k €
  2. 2024
    Annual accounts 2024277,5 k €
  3. 2023
    Annual accounts 2023317,3 k €
  4. 2022
    Annual accounts 2022264,5 k €
  5. 2021
    Annual accounts 2021234 k €
  6. 2020
    Annual accounts 2020143,9 k €
  7. 2019
    Annual accounts 2019249,8 k €
  8. 2018
    Annual accounts 2018245 k €
  9. 2017
    Annual accounts 2017154,8 k €
  10. 2016
    Annual accounts 2016144 k €
  11. 2015
    Annual accounts 2015124 k €
  12. 2014
    Annual accounts 201485,2 k €
  13. 2013
    Annual accounts 2013261,3 k €
  14. 2013
    Name changeMBM PHARMA
  15. 2012
    Annual accounts 2012181,6 k €
  16. 2011
    Annual accounts 2011156,5 k €
  17. 2010
    Annual accounts 2010179,7 k €
  18. 2009
    Annual accounts 2009189,8 k €
  19. 2008
    Annual accounts 2008113 k €
  20. 2007
    Annual accounts 2007127,6 k €
  21. 2006
    Annual accounts 2006109 k €
  22. 2006
    Name changeBUREAU MERCIER-BIOT-MERCIER
  23. 13/12/1994
    IncorporationPrivate company with limited liability